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1. Introduction 
Lysophosphatidylserine induces hyperglycaemia 
and brain glucose accumulation i  mice and rats. 
These effects are thought to originate from an induced 
secretion of histamine and adrenaline [1-3]. Experi- 
ments on isolated mast cells support his possibility 
since lysophosphatidylserine e hances the histamine 
release induced by antigens, concanavalin A or dextran 
[4,5]. Moreover, acationic protein eliciting histamine 
release from peritoneal mast cells in the presence of 
lysophosphatidylserine has been detected in mouse 
plasma [3,6]. Attempts to further purify this protein 
led to the unexpected finding that the effect on mast 
cells can be seen when the mouse blood is collected 
by a cut in the neck region and not by heart or tail 
puncture. Since contamination bynerve growth factor 
is common in blood of male mice collected from the 
neck region [7], a likely explanation for the difference 
was the presence of nerve growth factor in the active 
plasma preparations. These experiments confirm this 
possibility and demonstrate a powerful synergism 
between lysophosphatidylserine a dnerve growth 
factor on rat peritoneal mast cells. 
2. Material and methods 
SDS, 8 M urea. The single band of mouse/~-NGF had 
M r 12 500-13 500 when assessed by a titration curve 
with standard proteins. Cobra nerve growth yielded 
a major band of 25 000-26 000 M r. A minor band of 
12 500-13 500 M r indicated the partial splitting of 
the dimer under these conditions. Minor contamina- 
tions of high M r were also detected. On dissociated 
sensory ganglia from 8-day-old chick embryos [10], 
mouse ~-NGF elicited survival and fiber outgrowth at 
0.5 ng/ml, cobra nerve growth factor at 2 ng/ml. 
2.2. Rat peritoneal mast cells 
Mast cells were collected from the peritoneum of 
male albino rats and purified on a concentrated serum 
albumin solution as in [11]. About 3 × l0 s mast cells 
(3-5 tag histamine) were added to 1 ml balanced saline 
solution [11] containing 1mM CaC12, 10 mM glucose 
and 1 mg/ml serum albumin. When indicated, albumin 
was omitted. After the addition of nerve growth fac- 
tors the incubation was 15 min at 37°C. Lysophos- 
phatidylserine (0.5 taM) was added to the incubation 
medium before the nerve growth factor and equili- 
brated 5min with the mast cells. After centrifugation, 
the histamine was determined [12] in the supernatant 
and the release xpressed aspercent of total histamine 
obtained by heating the mast cells 5 min at 100°C in 
0.1 NHC1. 
2.1. Preparation o f  nerve growth factors 
Mouse/~-nerve growth factor (fl-NGF) was obtained 
from submaxillary glands of adult male albino mice as 
in [8]. Cobra (Na/a na/a) nerve growth factor was pre- 
pared as in [9]. Polyacrylamide g l electrophoresis of 
the 2 preparations was performed in 6% acrylamide, 
0.1% SDS. The samples were heated 3 min at 100°C 
in 5 mM phosphate buffer (pH 7) containing 0.5% 
2.3. L ysophospholipids 
Lysophosphatidylserine [1] and acetimidyl-lyso- 
phosphatidylserine [4]were prepared as described. 
Lysophosphatidylethanolamine was purchased from 
General Biochemicals. All phospholipids yielded a 
single spot when tested (0.1 tamol) on thin-layer 
chromatography with chloroform, methanol, acetic 
acid, water (25:15:4:2, by vol.) as developing solvent. 
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3. Results and discussion 
When the homogenate of submaxillary glands from 
adult male mice was tested on rat peritoneal mast 
cells, high histamine releasing activity was detected 
both in the presence and in the absence of lysophos- 
phatidylserine. Reducing protein to 5-10/ag/ml, the 
activity diminished but could be fully restored by the 
addition of 0.5/aM lysophosphatidylserine. The phos- 
pholipid-dependent ac ivity copurified with the nerve 
growth factor when the procedure in [13] was fol- 
lowed. To further investigate he interaction between 
lysophosphatidylserine a dnerve growth factor a 
purified preparation of the/3-subunit was obtained. 
This subunit is the active moiety of this complex pro- 
tein [8,14,15]. As a comparison, cobra nerve growth 
factor was prepared. Nerve growth factor from cobra 
venom is known to have the same biological activity 
as mouse protein but is poorly recognized by anti- 
bodies directed against it [9]. When the mouse #-NGF 
was tested on mast cells 2 effects could be observed 
(fig.1A). The first led to histamine release in the 
absence of lysophosphatidylserine a dreached its 
maximum at the highest concentrations employed 
(0.5-1.0/ag/ml). The second was manifest only in the 
presence of lysophosphatidylserine a dled to a his- 
tamine secretion at physiological/3-NGF concentra- 
tions (i.e., those active on dorsal root ganglia of chick 
embryos, 1.0-10 ng/ml). As indicated by the calcium 
dependence, bythe lack of lactate dehydrogenase 
activity in the supernatant and by the decrease of his- 
tamine release at 0°C, the 2 effects did not result from 
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Fig.1. Interaction on mast cells. (A) Mouse #-NGF without 
(~x) and with (o) 1 mg/ml serum albumin; mouse #-NGF + 
0.5 pM lysophosphatidylserine w thout (A) and with (e) serum 
albumin. (B) Cobra nerve growth factor without (o) and with 
(e) lysophosphatidylserine (the dashed line is the difference 
between the 2 curves); serum albumin was always added. 
mast cell damage. The addition of serum albumin to 
the incubation mixture allowed to control the first 
effect suggesting that aggregation of mast cells was 
involved in this case. Indeed,/3-NGF is known to 
increase cellular adhesiveness at a rather high concen- 
tration [16]. Albumin did not prevent the histamine 
release occurring in the presence of lysophosphatidyl- 
serine. Under these conditions, half-maximal stimula- 
tion by the/~-NGF was reached at 1-2 ng/ml corre- 
sponding to ~5 X 10-11 M on the basis of a dimer M r 
26 000. Lysophosphatidylserine which was used at 
1/37th of its critical micellar concentration (18.8/aM, 
[4]), did not elicit histamine release in the absence of 
#-NGF. In a comparison with compound 48•80, the 
histamine secretion i duced by lysophosphatidylserine 
plus/3-NGF was 70% of the maximum release promoted 
by this agent (70-75%). When cobra nerve growth 
factor substituted for the mouse proteins, the activity 
in the absence of lysophosphatidylserine was higher 
and could not be completely controlled by the addi- 
tion of serum albumin. However, the stimulation by 
lysophosphatidylserine was always manifest (fig.1B). 
In this case the lysophosphatidylserine-dependent 
activity (dashed line) reached its maximum at 50 ng/ 
ml. As shown in table 1, the effect of lysophosphatid- 
ylserine was dependent on the structure of the head- 
group. When the amino group of the serine was blocked 
(acetimidyl-lysophosphatidylserine) o  when the car- 
boxyl group was absent (lysophosphatidylethanol- 
amine) little or no activity was manifest. This struc- 
ture-activity relationship was similar to that observed 
in the enhancement of eoncanavalin A-induced hista- 
mine release [4]. When mast cells were preincubated 
with/3-NGF and washed, lysophosphatidylserine elic-
ited histamine release without he addition of the 
protein. This showed that the anionic phospholipid 
headgroup was not required for the binding of #-NGF 
to mast cells. The interaction between ~-NGF and 
lysophosphatidylserinecould be observed also in vivo. 
After local administration i  the paw of rats the hista- 
mine content was measured 18 h later. In 17 determi- 
nations 20/ag lysophosphatidylserine a d 10/ag/3-NGF 
injected separately reduced the histamine content 
from a control value of 82.31 + 2.65/ag/g wet wt to 
59.00 + 2.63 and 75.63 + 2.51, a decrease of 28_3% 
and 8.1%, respectively. When the 2 compounds were 
associated, the histamine content dropped to 
44.01 ± 2.38, a significant (P < 0.01) reduction of 
46.4%, even higher than the value expected from the 
simple additive ffect. The interaction between lyso- 
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Table 1 
Role of lysophosphatidylserine headgroup (% histamine r lease) 
System without fl-NGF +10 ng #-NGF/ml 
Untreated mast cells (11) 2.9 (0.3-9.5) 4.1 (2.9-11.0) 
+0.5 taM lysoPS (11) 4.3 (0.2-10.6) 42.0 (35.9-59.0) 
+0.5 taMlysoPEA (6) 3.2 (1.5-8.3) 8.5 (4.0-12.8) 
+0.5 #M acetimidyl-lysoPS (4) 5.4 (2.3-10.0) 9.3 (7.3-14.2) 
fl-NGF-treated mast cells (6) 
+0.5 laM lysoPS (6) 
3.6 (0.8-5.5) 3.7 (0.0-9.6) 
38.0 (26.9-69.0) 50.6 (33.1-68.0) 
1.5 X l0 s purified mast cells were treated with 0.1 tag fl-NGF 5 min at 20°C. The 
cells were centrifuged and washed once with a saline solution containing 1 mM 
CaC12, 10 mM glucose and 1 mg/ml bovine serum albumin. The data are mean 
values (range) of the experiments indicated in parenthesis 
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phosphatidylserine and fl-NGF in vivo could be rele- 
vant to explain the systemic effects elicited by the 
phospholipid administration. However, preliminary 
tests do not support his possibility since lysophos- 
phatidylserine r tains full effectiveness in mice after 
bilateral sialoadenectomy. 
The present results uggest that rat peritoneal mast 
cells possess receptors for nerve growth factor. These 
receptors are able to initiate the sequence of histamine 
secretion in the presence of lysophosphatidylserine 
and a minimal concentration (5 × 10 -11 M) of the 
ligand. The possibility that the receptors originate 
from bound IgE anti-mouse nerve growth factor seems 
unlikely since the rats had no contact with mice. Fur- 
thermore, rat serum did not prevent he effect of  
mouse nerve growth factor and both the mouse and 
the cobra preparations were active. The interaction 
between lysophosphatidylserine a dnerve growth 
factor on rat peritoneal mas(ceUs provides a simple, 
sensitive method to assay the biological activity of 
these compounds. In view of  the involvement of 
phospholipase A2 in the inflammatory response [ 17] 
and considering the possibility of nerve growth factor 
production in peripheral tissues [15], this test is suit- 
able to investigate the participation oflysophosphatid- 
ylserine and nerve growth factor-like proteins in a 
system of mast cell activation. 
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